Press release
Central Nervous System Therapeutic Market Trends, Size, Share and Forecast 2023-2029
The global central nervous therapeutics market is expected to grow at a CAGR of 7.5% during the forecast period. The growing number of central nervous disorders across the globe is significantly contributing to the growth of the global central nervous system therapeutic market. The prevalence of Alzheimer's disease, multiple sclerosis, epilepsy, Parkinson's disease, mental health and stroke are significantly growing across the globe. For instance, as per the World Health Organization (WHO), epilepsy is a chronic non-communicable disease of the brain which affects the brain around 50 million people across the globe are suffering from this disease and is one of the most common neurological diseases. Depression is a common mental disorder, around 5% of adults across the globe suffered from depression. It is a leading cause of disability across the globe. This, in turn, is driving the demand for treatment for these disorders, which in turn, is accelerating the market growth.To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/central-nervous-system-therapeutic-market
Some new launches of CNS drugs have been witnessed across the globe. For instance, in April 2021, Optimus Pharma announced that it has received approval for its Anti-Parkinson drug Safinamide in India. Safinamide is indicated as adjunctive treatment to levodopa/carbidopa in patients with Parkinson's disease (PD) experiencing "off" episodes. Optimus believes Safinamide will give an additional option to healthcare professionals in the treatment of Parkinson's and improve the quality of life of millions who are affected by Parkinson's disease. A homegrown generic version of Safinamide developed by Optimus will assist in delivering robust treatment for Parkinson's diseases in India with very high affordability and accessibility.
Market Coverage
• The market number available for - 2021-2028
• Base year- 2021
• Forecast period- 2022-2028
• Segment Covered-
o By Indication
o By Application
o By Drug Class
• Regions Covered-
o North America
o Europe
o Asia-Pacific
o Rest of the World
• Competitive Landscape- Johnson & Johnson Services Inc., Merck & Co. Inc., Novartis AG, Biogen Inc., and Eli Lilly, and Company Inc.
Key questions addressed by the report
• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• How COVID-19 impacted the market?
o Deviation from the pre-COVID-19 forecast
o Most affected region and segment
• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?
Global Çentral Nervous Therapeutic Market Report by Segment
By Indication
• Neurovascular Diseases
• CNS Trauma
• Mental Health
• Neurodegenerative Diseases
• Infectious Diseases
• Cancer
By Application
• Hospital & Clinic
• Homecare
• Others
By Drug Class
• Immunomodulatory Drugs
• Interferons
• Decarboxylase Inhibitors
• Dopamine Agonists
• Antidepressants
• Others
A full report of Central Nervous System Therapeutic Market is available at: https://www.omrglobal.com/industry-reports/central-nervous-system-therapeutic-market
Central Nervous System Therapeutic Market- Segment by Region
North America
• United States
• Canada
Europe
• Germany
• United Kingdom
• France
• Spain
• Italy
• Rest of Europe
Asia-Pacific
• China
• Japan
• India
• Rest of Asia-Pacific
Rest of the World
• Middle East & Africa
• Latin America
Company Profiles
• AstraZeneca plc
• Cipla Ltd.
• CNS Pharmaceuticals, Inc.
• F. Hoffmann-La Roche Ltd.
• GlaxoSmithKline plc
• H. Lundbeck A/S
• Lupin Ltd.
• Medopharm Private Ltd.
• Neurelis, Inc.
• Nuventra Pharma Sciences
• Otsuka Pharmaceutical Co., Ltd.
• Pfizer Inc.
• Sanofi S.A.
• Shire plc
Reasons to Buying From us -
1. We cover more than 15 major industries, further segmented into more than 90 sectors.
2. More than 120 countries are for analysis.
3. Over 100+ paid data sources mined for investigation.
4. Our expert research analysts answer all your questions before and after purchasing your report.
Visit More Report at
https://www.asiatimeskorea.com/press-release/%ea%b4%91%ea%b2%ac%eb%b3%91-%eb%a9%b4%ec%97%ad%ea%b8%80%eb%a1%9c%eb%b6%88%eb%a6%b0-%ec%8b%9c%ec%9e%a5-%ec%84%b1%ec%9e%a5-%ec%a0%90%ec%9c%a0%ec%9c%a8-%eb%8f%99%ed%96%a5-%eb%b0%8f-%ea%b0%9c%ec%9a%94-2/170451/
https://www.diario-ya.com/regionales/2022-2028-%e5%b9%b4%e7%b4%a7%e6%80%a5%e5%8c%bb%e7%96%97%e6%9c%8d%e5%8a%a1%e5%b8%82%e5%9c%ba%e8%a7%84%e6%a8%a1%e3%80%81%e4%bb%bd%e9%a2%9d%e3%80%81%e8%a1%8c%e4%b8%9a%e5%a2%9e%e9%95%bf%e3%80%81%e5%88%86/251616/
https://sportmsr.com/%d8%ad%d8%ac%d9%85-%d8%b3%d9%88%d9%82-%d9%86%d8%b8%d9%85-%d9%85%d8%b1%d8%a7%d9%82%d8%a8%d8%a9-%d9%86%d8%b3%d8%a8%d8%a9-%d8%a7%d9%84%d8%ac%d9%84%d9%88%d9%83%d9%88%d8%b2-%d9%81%d9%8a-%d8%a7%d9%84%d8%af/
https://revistaeconomiasocial.com/2022/12/12/copa-menstrual-tamano-del-mercado-participacion-crecimiento-de-la-industria-analisis-y-pronostico-2022-2028/
https://hy-icehockey.jp/%e3%83%86%e3%82%af%e3%83%8e%e3%83%ad%e3%82%b8%e3%83%bc/%e5%a4%96%e6%9d%a5ehr%e5%b8%82%e5%a0%b4%e3%81%ae%e6%88%90%e9%95%b7%e3%80%81%e3%82%b7%e3%82%a7%e3%82%a2%e3%80%81%e5%82%be%e5%90%91%e3%80%81%e3%81%8a%e3%82%88%e3%81%b3%e6%a6%82%e8%a6%812022%e5%b9%b4/51838/
Media Contact:
Contact Person: Mr. Anurag Tiwari
Email: anurag@omrglobal.com
Contact no: +91 780-304-0404
Company Name: Orion Market Research
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Central Nervous System Therapeutic Market Trends, Size, Share and Forecast 2023-2029 here
News-ID: 2910233 • Views: …
More Releases from Orion Market Research

Direct Attach Cable Market Analysis Current Landscape and Future Outlook
The global Direct Attach Cable (DAC) market was valued at approximately USD 1.77 billion in 2024 and is projected to reach around USD 11.9 billion by 2033, growing at a compound annual growth rate (CAGR) of 20.6% from 2025 to 2033.
Request a sample copy of this report at: https://www.omrglobal.com/request-sample/direct-attach-cable-market
Direct Attach Cable Market Overview:
The Direct Attach Cable (DAC) market is witnessing robust growth due to the increasing demand for high-speed, cost-effective…

Automatic Route Control System Market Size Unlocking New Opportunities for Succe …
The global Automatic Route Control System (ARCS) market was valued at approximately USD 2.5 billion in 2022 and is projected to reach USD 4.1 billion by 2030, reflecting a compound annual growth rate (CAGR) of 7.2% from 2025 to 2033.
Request a sample copy of this report at: https://www.omrglobal.com/request-sample/automatic-route-control-system-market-share
Automatic Route Control System Market Overview:
The Automatic Route Control System (ARCS) market is experiencing significant growth, driven by the increasing demand for efficient…

Intelligent Road System Market Accelerating Growth with Future Market Size Strat …
The global Intelligent Road System (IRS) market is projected to reach USD 58.6 billion in 2024 and is anticipated to grow to USD 118.1 billion by 2033, reflecting a compound annual growth rate (CAGR) of 5.8% from 2025 to 2033.
Request a sample copy of this report at: https://www.omrglobal.com/request-sample/intelligent-road-system-market
Intelligent Road System Market Overview:
The Intelligent Road System (IRS) market is focused on creating smart transportation infrastructure that enhances road safety, efficiency, and…

Hemostasis Products Market Accelerating Growth with Future Market Size Strategie …
As of 2024, the global hemostasis products market is estimated to be valued at approximately USD 1.9 billion. It is projected to reach around USD 3.1 billion by 2033, reflecting a compound annual growth rate (CAGR) of 5.58% from 2025 to 2033.
Request a sample copy of this report at: https://www.omrglobal.com/request-sample/hemostasis-products-market
Hemostasis Products Market Overview:
The hemostasis products market is a critical segment of the medical industry, focused on products used to control…
More Releases for Parkinson
QualitySolicitors Parkinson Wright invest in the future
QualitySolicitors Parkinson Wright has selected Liberate from Linetime as its business-wide legal services software platform. The Worcestershire based practice, with over 100 staff, operate from 4 offices and have a highly regarded reputation for their services including residential property, private client, family, dispute resolution and commercial. The firm also has its own estate agency.
The firm recognised that to continue delivering high quality services to its clients it needed to provide…
Wolff Parkinson White syndrome Market found Future opportunities of 2023
The Analysis presents the study of Global Wolff Parkinson White syndrome Market facilitating the regional and country wise analysis covering the strategic analysis of each market player and the market share they hold
Wolff Parkinson White Syndrome Market Information: By Types (Type A, Type B) By Diagnosis (Electrocardiogram (ECG), Electrophysiological Testing, Others) By Treatment (Drugs (Anti-Arrhythmic, Beta-Blockers, Others), Cardioversion, Radiofrequency Catheter Ablation, Surgery, Artificial Pacemaker, Others) By End Users - Global…
PARKINSON RESEARCH FOUNDATION Announces Director of Patient Programs, Services a …
The Parkinson Research Foundation is pleased to announce that Marilyn Tait has joined the foundation as the Director of Patient Programs, Services and Advocacy. Tait, is a graduate of Thomas Jefferson University School of Nursing in Philadelphia, Pennsylvania. Tait has forty years experience in healthcare marketing and program development. After specializing in oncology for 30 years, Tait embarked on her new career at a time in her life when…
PARKINSON RESEARCH FOUNDATION’S (PRF) WESTERN CARIBBEAN FOURTH EDUCATIONAL CRU …
The Parkinson Research Foundation (PRF), a non-profit organization with a dedicated patient education program, will return to the Western Caribbean for its fourth educational cruise. PRF developed its educational cruise program to give Parkinson patients, caregivers family and loved ones unrivaled access to experts in the movement-disorder field.
After visiting the Bahamas and Alaska on the first two respective PRF cruises, PRF’s ventured to the Western Caribbean on its most…
PARKINSON RESEARCH FOUNDATION (PRF) Develops New Patient Outreach Program
One of the principal missions of the Parkinson Research Foundation (PRF) that distinguishes it from other Parkinson organizations is PRF’s focus on patient education; specifically education that enables Parkinson patients and their caregivers to live fuller and more comfortable lives with Parkinson's disease.
The Foundation’s educational events, including educational cruises, gather leading Parkinson experts, therapists and nutritionists from across the country to offer life-changing tools and knowledge for individuals affected…
Parkinson`s Disease:New Hope Educational Conference
PARKINSON’S DISEASE: NEW HOPE EDUCATIONAL CONFERENCE
Become knowledgeable about the advancements in surgery
The Parkinson Research Foundation is proud to announce that Dr. James Schumacher will be speaking about advances in surgery at our fourth annual New Hope for Parkinson’s conference on November 1st in Boca Raton. Dr. Schumacher is an internationally known expert in the field of neurosurgical treatment of Parkinson’s disease and movement disorders. He has an extensive background and…